Multiple Myeloma Stage I
3 clinical trials · Condition
◉ Watch Multiple Myeloma Stage I
| Record | Firm | Date |
|---|---|---|
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma (NCT03428373) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-01-17 |
| Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation (NCT03792620) | Grupo de Estudos Multicentricos em Onco-Hematologia | 2018-11-20 |
| Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I (NCT00171925) | Novartis Pharmaceuticals | 2000-08-01 |
Track Multiple Myeloma Stage I automatically
Every clearance here is in the API, with alerts when new ones post.